BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1986577)

  • 41. Whole-pulmonary low-dose radiation therapy in agnogenic myeloid metaplasia with diffuse lung involvement.
    Weinschenker P; Kutner JM; Salvajoli JV; Hanriot RM; Ribeiro AF; Capelozzi VL; Del Giglio A
    Am J Hematol; 2002 Apr; 69(4):277-80. PubMed ID: 11921022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant histiocytosis in a patient presenting with hepatic dysfunction and peliosis hepatis.
    Fine KD; Solano M; Polter DE; Tillery GW
    Am J Gastroenterol; 1995 Mar; 90(3):485-8. PubMed ID: 7872292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splenectomy in agnogenic myeloid metaplasia.
    Porcu P; Neiman RS; Orazi A
    Blood; 1999 Mar; 93(6):2132-4. PubMed ID: 10189205
    [No Abstract]   [Full Text] [Related]  

  • 45. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Massive intrahepatic extramedullary hematopoiesis in myelofibrosis.
    Navarro M; Crespo C; Pérez L; Martínez C; Galant J; González I
    Abdom Imaging; 2000; 25(2):184-6. PubMed ID: 10675463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous extramedullary hematopoiesis in myelofibrosis.
    Mizoguchi M; Kawa Y; Minami T; Nakayama H; Mizoguchi H
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 2):351-5. PubMed ID: 2406300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agnogenic myeloid metaplasia with a parotid mass.
    Levine LA; Ansel DG; Murray JP
    Arch Otolaryngol; 1979 Apr; 105(4):205-6. PubMed ID: 426709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Agnogenic myeloid metaplasia and spinal cord compression.
    Jacobs P; Dubovsky D; Commerford P; Price S; Handler L
    S Afr Med J; 1979 Feb; 55(7):256-9. PubMed ID: 441867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Portal hypertension complicating myelofibrosis: reversal following splenectomy.
    Lukie BE; Card RT
    Can Med Assoc J; 1977 Oct; 117(7):771-2. PubMed ID: 907949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 52. Myelofibrosis, hepatic extramedullary hematopoiesis and ascites associated with vitamin D deficiency in early infancy.
    Henry M; Chitlur M; Rajpurkar M; Mastropietro CW; Poulik J; Ravindranath Y
    J Pediatr Hematol Oncol; 2014 May; 36(4):319-21. PubMed ID: 23619118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A case of cutaneous extramedullary hematopoiesis associated with idiopathic myelofibrosis].
    Corella F; Barnadas MA; Bordes R; Curell R; Espinosa I; Vergara C; Alomar A
    Actas Dermosifiliogr; 2008 May; 99(4):297-300. PubMed ID: 18394406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transjugular intrahepatic porto-systemic stent-shunt for therapy of bleeding esophageal varices due to extramedullary hematopoiesis in primary myelofibrosis: a case report.
    Phillip V; Berger H; Straub M; Saugel B; Treiber M; Einwächter H; Schmid RM; Huber W
    Onkologie; 2012; 35(6):368-71. PubMed ID: 22722458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
    Ward HP; Block MH
    Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717
    [No Abstract]   [Full Text] [Related]  

  • 56. Pericardial tamponade associated with myeloid metaplasia.
    Bubley G; Come P; MacDougall D; Thurer R; Goldberg J
    Am J Hematol; 1983 Apr; 14(2):185-8. PubMed ID: 6837572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute agnogenic myeloid metaplasia with chromosomal abnormalities.
    Bartoli E; Massarelli G; Soggia G; Tanda F; Vianello MG
    Acta Haematol; 1979; 62(4):206-13. PubMed ID: 119413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia.
    Wolf BC; Neiman RS
    Hematol Pathol; 1987; 1(1):77-80. PubMed ID: 3332874
    [No Abstract]   [Full Text] [Related]  

  • 59. [Extensive intra-abdominal tumor masses in primary osteomyelofibrosis].
    Krause MW; Maire R
    Schweiz Med Wochenschr; 1985 Jan; 115(1):24-9. PubMed ID: 3969539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nature and incidence of liver involvement in agnogenic myeloid metaplasia.
    Ligumski M; Polliack A; Benbassat J
    Scand J Haematol; 1978 Aug; 21(2):81-93. PubMed ID: 308689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.